ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Cardiovascular Epidemiology and Prevention
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1570390
Global burden of Hypertensive heart disease attributable to High body mass index from 1990 to 2021: A multidimensional analysis and public health response
Provisionally accepted- 1Shandong University of Traditional Chinese Medicine, Jinan, China
- 2Shengli Oilfield Central Hospital, Dongying, Shandong Province, China
- 3Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background As the global population of obese individuals surpasses 878 million, the impact of high body mass index (BMI) on hypertensive heart disease (HHD) has risen to the third position among all diseases. However, the specific contribution of high BMI to the burden of HHD remains unclear. Methods Data on deaths, disability-adjusted life years (DALYs), and their age-standardized rates (ASR) were obtained from the Global Burden of Disease (GBD) database. Population attributable fractions (PAF) was used to assess the contribution of risk factors. Various analytical methods, including decomposition analysis, cluster analysis, frontier analysis, age-period-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis, were employed to investigate changes in disease burden. Results The results showed an increasing global burden of HHD due to high BMI, with both mortality and DALYs doubling over the past 30 years. Their ASR also continued to rise. By 2021, the PAF for deaths and DALYs reached 44% and 49%, respectively. Population growth and aging were significant contributors to this disease burden. Low- and middle- Socio-Demographic Index (SDI) regions experienced the highest burden, particularly in East Asia, South Asia, North Africa and Middle East. Although the disease burden was lower in high income areas, the increase was notable, especially in North America. Women and older populations faced higher risks, particularly alarming is the rapid increase in risk among younger populations in high SDI regions. Conclusion HHD resulting from high BMI poses a significant global public health challenge, particularly in regions with middle and low SDI. While the heightened risk among women and older individuals has garnered considerable attention, the increasing risk among younger populations also necessitates greater focus. Targeted interventions should prioritize diet, exercise, medical security, and health education, with particular emphasis on enhancing policy support for low-income and high-risk groups. Future policies must integrate the social, economic, and cultural contexts of each region, implement comprehensive prevention and control strategies, and establish a multi-dimensional health promotion system.
Keywords: high body mass index, Hypertensive heart disease, disability-adjusted life years, Mortality, Global burden
Received: 06 Feb 2025; Accepted: 25 Jul 2025.
Copyright: © 2025 Sun, Zhang, Cong, Zhang, Lv, Xie and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shouqiang Chen, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.